GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Zimmer Holdings, Inc. (ZBH) [hlAlert]

Rating:
Hold ZMH
up 16.98 %

Zimmer Holdings, Inc. (ZMH) downgraded to Hold by Standpoint Research

Posted on: Thursday,  Jan 26, 2012  11:25 AM ET by Standpoint Research

Standpoint Research rated Hold Zimmer Holdings, Inc. (NYSE: ZBH) on 01/26/2012. Previously Standpoint Research rated Buy Zimmer Holdings, Inc. (NYSE: ZBH) on
08/19/2011., when the stock price was $51.10. Since then, Zimmer Holdings, Inc. has gained 16.99% as of 01/26/2012's recent price of $59.78.
If you would have followed the previous Standpoint Research's recommendation on ZBH, you would have gained 16.98% of your investment in 160 days.

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Its primary customers include musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent surgeons. It has operations in more than 25 countries and market products in more than 100 countries. In October 2008, the Company acquired Abbott Spine. It markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and, in the Asia Pacific region, healthcare dealers, and directly to dental practices and dental laboratories.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/26/2012 11:25 AM Hold
None
59.78
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/19/2011 2:25 PM Buy
None
51.10
4/27/2011 2:25 PM Hold
None
62.36

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy